|
by The Exposé
September 21, 2023
from
Expose-News Website
Information sent by MJGdeA
DARPA has openly bragged on Twitter
that Moderna's
mRNA vaccine technology, and by
extension Moderna's Covid vaccine, was a product of their ADEPT
program.
Below, Spartacus takes a look at the paper trail that
shows Moderna is just another front in the Biodefence Mafia.
The introduction of foreign nucleic acids - RNA or DNA - into the
body to generate foreign proteins is, by definition, gene therapy,
regardless of whether or not the subject's own genes are changed by
it.
Cationic lipids, like the lipid nanoparticles used in mRNA vaccines,
are capable of transfecting basically any type of cell with
instructions to make proteins. If the immune system catches a cell
producing non-human proteins, some seriously bad things will happen
to that cell.
There has been a major push for the adoption of nucleic acid vaccine
tech in prior years, largely hidden from the public eye.
In order to begin tracing
it out, one must simply perform date range searches for the years
prior to 2020, for nucleic acid vaccines. The cheerleaders of this
technology immediately reveal themselves.
And they are all looking
for technology that is easy, rapid, and cost-effective for
development and manufacture.
Naturally, the military would be interested in this technology for
quickly vaccinating large populations of people against bioweapons
ahead of pandemic spread, because it offers the potential for rapid
development and deployment of countermeasures in a wartime scenario
with equally rapid-developed bioweapons being flung all over the
place.
This is where DARPA's
ADEPT comes in.
DARPA openly brag on Twitter that Moderna's mRNA vaccine technology,
and by extension Moderna's Covid vaccine, was a product of ADEPT.
As Stat News
reported:
"A review of dozens
of patent applications found [Moderna] received approximately
$20 million from the federal government in grants several years
ago and the funds "likely" led to the creation of its vaccine
technology.
This was used to
develop vaccines to combat different viruses, such as Zika and,
later, the virus that causes Covid-19."
Corporate media, with few
exceptions, are largely silent on this matter.
The reason you have been
kept in the dark is because you are the target of a globe-spanning
military operation, with population reduction, mass surveillance,
tyrannical control of people's movements, and the destruction of
human autonomy through implanted technology as its end goal.
Read related below
inserted report...
Nucleic
Acid Vaccines
A nucleic acid
vaccine is a vaccine that uses gene delivery methods, such as lipid
nanoparticles or viral vectors, to deliver some quantity of either
DNA or RNA into a cell.
The cell's own machinery, in the form of RNA
polymerases and ribosomes, uses these nucleic acids as instructions
to synthesize proteins.
In the case of a nucleic acid vaccine, the
protein in question is usually one of the structural proteins of a
virus, with the aim of generating an antibody response against that
specific protein, but this isn't the only type of product that
nucleic acid transfection can produce.
Gene transfection into cells
can, in fact, make those cells produce any kind of protein, with the
right instructions, including monoclonal antibodies, designer
receptors, anything imaginable.
In the case of the
Covid-19 vaccines, the media and the medical establishment tried
getting around this by arguing that since the vaccines did not
change the recipient's DNA, that meant that they weren't gene
therapy.
The introduction of foreign nucleic acids into the body
to generate foreign proteins is,
by definition, gene therapy, regardless of whether or not the
subject's own genes are changed by it. DNA and RNA are genetic
material, and if the immune system catches a cell producing
non-human proteins, some
seriously
bad things will happen to that cell.
Unlike a virus - which only binds to specific host factors expressed by specific cell
lines and is endocytosed in those specific cells - cationic lipids,
like the lipid nanoparticles ("LNPs") used in mRNA vaccines, are
capable of transfecting basically any type of cell with instructions
to make proteins.
LNPs were investigated for many years as a means
of delivering Alzheimer's drugs to the brain because they readily
bypass the blood-brain barrier.
When the thing
being delivered is a toxin, like SARS-CoV-2 Spike, however, there
are serious consequences.
MDPI - A Case Report: Multifocal
Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA
Vaccination against Covid-19:
The current
report presents the case of a 76-year-old man with Parkinson's
disease (PD) who died three weeks after receiving his third
Covid-19 vaccination.
The patient was
first vaccinated in May 2021 with the ChAdOx1 nCov-19 vector
[AstraZeneca] vaccine, followed by two doses of the BNT162b2
mRNA [Pfizer-BioNTech] vaccine in July and December 2021.
The family of
the deceased requested an autopsy due to ambiguous clinical
signs before death. PD was confirmed by post-mortem
examinations. Furthermore, signs of aspiration pneumonia and
systemic arteriosclerosis were evident.
However, histopathological analyses of the brain uncovered previously
unsuspected findings, including acute vasculitis (predominantly
lymphocytic) as well as multifocal necrotising encephalitis of
unknown aetiology with pronounced inflammation including glial
and lymphocytic reaction.
In the heart, signs of chronic cardiomyopathy as well as mild acute lympho-histiocytic
myocarditis and vasculitis were present.
Although there
was no history of Covid-19 for this patient,
immunohistochemistry for SARS-CoV-2 antigens (spike and
nucleocapsid proteins) was performed.
Surprisingly,
only
spike protein but no nucleocapsid protein
could
be detected within the foci of inflammation in both
the brain and the heart, particularly in the
endothelial cells of small blood vessels.
Since no
nucleocapsid protein could be detected,
the presence of
spike protein must be ascribed to vaccination rather
than to viral infection.
The findings corroborate
previous reports of encephalitis and myocarditis caused by
gene-based Covid-19 vaccines.
There has been a
major push for the adoption of nucleic acid vaccine tech in prior
years, largely hidden from the public eye.
In order to begin tracing
it out, one must simply perform date range searches for the years
prior to 2020, for nucleic acid vaccines.
The cheerleaders of this
technology immediately reveal themselves.
Easy,
Rapid, Cost-Effective Development and Manufacture
Nature - mRNA vaccines - a new era in vaccinology:
mRNA vaccines
represent a promising alternative to conventional vaccine
approaches because of their high potency,
capacity for
rapid development and potential for low-cost manufacture
and safe administration.
However, their application has until
recently been restricted by the instability and inefficient in
vivo delivery of mRNA.
Recent
technological advances have now largely overcome these issues,
and multiple mRNA vaccine platforms against infectious diseases
and several types of cancer have demonstrated encouraging
results in both animal models and humans.
This Review provides a
detailed overview of mRNA vaccines and considers future
directions and challenges in advancing this promising vaccine
platform to widespread therapeutic use.
Frontiers - Advances in mRNA Vaccines
for Infectious Diseases:
During the last
two decades, there has been broad interest in RNA-based
technologies for the development of prophylactic and therapeutic
vaccines.
Preclinical and
clinical trials have shown that mRNA vaccines provide a safe and
long-lasting immune response in animal models and humans.
In
this review, we summarize current research progress on mRNA
vaccines, which have the potential to be
quick-manufactured and to become powerful tools against
infectious disease and we highlight the bright future of their
design and applications.
International Journal of Nanomedicine
- Development of nucleic acid vaccines: use of self-amplifying RNA
in lipid nanoparticles:
Self-amplifying
RNA or RNA replicon is a form of nucleic acid-based vaccine
derived from either positive-strand or negative-strand RNA
viruses.
The gene sequences encoding structural proteins in
these RNA viruses are replaced by mRNA encoding antigens of
interest as well as by RNA polymerase for replication and
transcription.
This kind of vaccine has been successfully
assayed with many different antigens as vaccine candidates, and
has been shown to be potent in several animal species, including
mice, nonhuman primates, and humans.
A key challenge
to realizing the broad potential of self-amplifying vaccines is
the need for safe and effective delivery methods.
Ideally, an
RNA nanocarrier should provide protection from blood nucleases
and extended blood circulation, which ultimately would increase
the possibility of reaching the target tissue.
The delivery
system must then be internalized by the target cell and, upon
receptor-mediated endocytosis, must be able to escape from the
endosomal compartment into the cell cytoplasm, where the RNA
machinery is located, while avoiding degradation by lysosomal
enzymes.
Further, delivery systems for systemic administration
ought to be well tolerated upon administration.
They should be
safe, enabling the multi-administration treatment modalities
required for improved clinical outcomes and, from a
developmental point of view,
production of large batches
with reproducible specifications is also desirable.
In this review,
the concept of self-amplifying RNA vaccines and the most
promising lipid-based delivery systems are discussed.
Nature Gene Therapy - The promise of
nucleic acid vaccines:
Establishing
the effective use of 'naked' nucleic acids as vaccines would
undoubtedly be one of the most important advances in the history
of vaccinology.
While nucleic
acids show much promise for use as vaccine vectors in
experimental animals, not a single naked nucleic acid vector has
been approved for use in humans.
Indeed, data from human
clinical trials is scant:
nucleic acid vaccines have not been
clearly demonstrated to have any convincing efficacy in the
prevention or treatment of infectious disease or cancer.
Here we
illustrate possible mechanisms underlying effective nucleic acid
vaccination.
We focus on progress that has been made in the
improvement of their function.
Additionally, we identify
promising new strategies and try to forecast future developments
that could lead to the real success of nucleic acid vaccines in
the prevention and treatment of human disease.
Cell Press Molecular Therapy - Self-Amplifying RNA Vaccines Give Equivalent Protection against
Influenza to mRNA Vaccines but at Much Lower Doses:
New vaccine
platforms are needed to address the time gap between
pathogen emergence and vaccine licensure.
RNA-based
vaccines are an attractive candidate for this role:
they are
safe, are produced cell free, and can be rapidly generated in
response to pathogen emergence.
Two RNA vaccine
platforms are available:
sa-RNA
is virally derived and encodes both the antigen of interest and
proteins enabling RNA vaccine replication.
Both platforms have
been shown to induce an immune response, but it is not clear
which approach is optimal. In the current
studies, we compared synthetic mRNA and sa-RNA expressing
influenza virus hemagglutinin.
Both platforms were protective,
but equivalent levels of protection were achieved using 1.25 μg
sa-RNA compared to 80 μg mRNA (64-fold less material).
Having
determined that sa-RNA was more effective than mRNA, we tested
hemagglutinin from three strains of influenza H1N1, H3N2 (X31),
and B (Massachusetts) as sa-RNA vaccines, and all protected
against challenge infection.
When sa-RNA was combined in a
trivalent formulation, it protected against sequential H1N1 and
H3N2 challenges.
From this we conclude that sa-RNA is a
promising platform for vaccines against viral diseases.
Again and again,
the same properties are touted:
easy, rapid, cost-effective
development and manufacture...
Plug in a gene sequence for the
targeted antigen and away you go.
Naturally, the
military would be interested in this technology for quickly
vaccinating large populations of people against bioweapons ahead of
pandemic spread, because it offers the potential for rapid
development and deployment of countermeasures in a wartime scenario
with equally rapid-developed bioweapons being flung all over the
place.
ADEPT:
PROTECT
ADEPT is a
Defence
Advanced Research Projects Agency ("DARPA") program that began in
2012.
The acronym stands for
Autonomous Diagnostics to Enable
Prevention and Therapeutics.
PROTECT is a sub-program of
ADEPT, and
it stands for 'Prophylactic Options to Environmental and
Contagious
Threats.'
Some quick searches
reveal presentation slides about the project:
Autonomous Diagnostics to Enable Prevention and Treatment (ADEPT)
PROTECT provides
prophylactic protection against disease by treating people with
nucleic acid constructs that encode protective monoclonal
antibodies.
And in the next image taken from a document titled 'ADEPT - PROTECT',
"DARPA pioneered the use of the body as a bioreactor to produce
prophylactic antibodies to protect against biothreats."
ADEPT Vignette Final
Apparently, the goal of ADEPT: PROTECT was to come up with nucleic
acid delivery systems that encoded monoclonal antibodies (or mAbs)
against specific pathogens that may be used in biowarfare, such as,
influenza, smallpox, SARS, chikungunya, rabies, anthrax bacteria,
and even ricin, nerve agents, and prions...
Antibodies are the means by which the adaptive immune system tags
things for destruction and disposal.
They lock over the surface
proteins of pathogens and guide inactivated viruses and bacteria
into leukocytes, encourage complement activation, and so on.
Monoclonal antibodies are essentially copies of one specific kind of
antibody, for therapeutic use.
This differs slightly from how mRNA
vaccines have ended up being used; generating the target antigen
protein instead, and letting the body manufacture antibodies against
it.
In DARPA's own words, they partnered with Moderna to produce
mRNA-1944, a nucleic acid-encoded mAb against chikungunya...:
In fact, DARPA openly
brag on Twitter that Moderna's mRNA vaccine tech - and, by
extension, mRNA-1273 (Moderna's Covid vaccine), was a product of
ADEPT:
Another company
involved in ADEPT is Ichor Medical
Systems, a little-known company in San Diego specializing in
electroporation gene delivery tech that partners with Pfizer,
Janssen, and USAMRIID.
Ichor Awarded DARPA ADEPT: PROTECT
Contract:
Ichor Medical Systems of
San Diego has been awarded a contract through the Defence
Advanced Research Projects Agency (DARPA) and supported by the
US Army Research Office for up to $20.2 million of funding over
five years, including a base period award of $8.6M.
The award is
part of a DARPA program called Autonomous Diagnostics to Enable
Prevention and Therapeutics: Prophylactic Options to
Environmental and Contagious Threats (ADEPT: PROTECT) aimed at
developing new platform technologies that could be safely and
rapidly deployed to the US population and military personnel to
provide immediate protection in the event of an infectious
outbreak or biological weapons attack.
The program
will fund the development and clinical assessment of Ichor's
TriGrid electroporation system as a DNA-based antibody delivery
platform to produce protective antibodies for passive
immunoprophylaxis.
What's really going
on, here?
Why haven't the media extensively covered the military
think tank side of all of this, as well as DARPA's enduring
partnership with Moderna?
Moderna failed to disclose federal
funding for vaccine patent applications, advocates say:
An advocacy
group has asked the Department of Defence to investigate what it
called "an apparent failure" by Moderna (NASDAQ:MRNA)
to disclose millions of dollars in awards received from the
Defence Advanced Research Projects Agency in patent applications
the company filed for vaccines.
In a letter to
the agency, Knowledge Ecology International explained that a review of
dozens of patent applications found the company received
approximately $20 million from the federal government in grants
several years ago and the funds "likely" led to the creation of
its vaccine technology.
This was used to develop vaccines to
combat different viruses, such as Zika and, later, the virus
that causes Covid-19.
In arguing for
an investigation, the advocacy group maintained Moderna is
obligated under federal law to disclose the grants that led to
nearly a dozen specific patent applications and explained the
financial support means the US government would have certain
rights over the patents.
In other words, US taxpayers would have
an ownership stake in vaccines developed by the company.
There is an
extensive paper trail, here, one that shows that Moderna is just
another front in the Biodefence Mafia. The media, with few
exceptions, are largely silent on this matter.
If we are at war - and at this point, only an idiot would fail to see that we are
- then,
Who fired the first shot?
Why are world leaders so tight-lipped
about all of this?
Well, it's simple, really.
The reason why you
have been kept in the dark is because you are the target of
a globe-spanning military operation, with,
In all of the
affluent nations operating under the globalist managerial
rules-based order of private-public partnerships, NGOs, and
supranational organizations, the only real threats to the ruling
class are,
-
resurgent nationalism
-
populism
-
traditionalism,
...because these things invariably lead to protectionist economic
policies that divert resources away from the already magnificently
wealthy ruling class and towards the middle.
Populism is only a
problem for the rich and powerful if there are people to embody it.
No people, no problem...!
Hence the reliance on
bioweapons and
poisonous vaccines.
The Neo-Malthusian ruling class want to kill off,
...and
keep the
valuable infrastructure intact, and profit off of it, after they
corral just enough survivors to keep their global consumerist orgy
going.
They aren't even
discreet about it.
They openly revel in their extraordinarily
'grandiose ideas'...!
Carnegie Council for
Ethics in International Affairs:
Yuval Noah Harari, Workplace
Automation & the "Useless Class",
13 March 2017
These people want
to control you, and if they can't control you, then they want to
replace you with someone they can.
The word for this condition is
megalomania...
Merriam-Webster - Megalomania:
meg·a·lo·ma·nia, me-gə-lō-ˈmā-nē-ə -nyə
1: a
mania (see MANIA
sense 2a) for great or
grandiose performance an outburst of wildly extravagant
commercial megalomania The Times Literary
Supplement (London)
2: a
delusional mental
illness that is marked by
feelings of personal omnipotence and grandeur
megalomaniac, me-gə-lō-ˈmā-nē-ˌak adjective
or noun
megalomaniacal, me-gə-lō-mə-ˈnī-ə-kəl adjective or
less commonly megalomanic, me-gə-lō-ˈma-nik
megalomaniacally, me-gə-lō-mə-ˈnī-ə-k(ə-)lē adverb
We must throw all
of our energy into exposing these people and dismantling their
tyrannical institutions.
As they have
clearly violated the social contract and are scrambling desperately
to conceal that fact, there is no point whatsoever in obeying them.
Their authority is now illegitimate.
We have every right
to defend ourselves and our kin from murderous despots who plot
against us in the dark.
The Real Reason why...
Moderna is Suing Pfizer
by The Exposé
October 14, 2022
from
Expose-News Website
The real
reason Moderna is suing Pfizer.
Moderna
helped create COVID-19 and patented "Virus" in 2013,
allowing
Moderna to develop a COVID Vaccine
before World
knew COVID-19 even Existed
Your Government has given companies like
Pfizer and Moderna immunity from liability if you are injured by their Covid-19
vaccines.
With this law, they
cannot be taken to court for damages.
So if you are one of the many who have been
injured, or lost a
loved one due to
Covid-19 vaccination, then you may feel
frustrated that Moderna is now suing Pfizer for alleged patent
infringement over mRNA Covid-19 injections.
But that frustration will turn to anger and disbelief once you
discover the real reason Moderna is now suing Pfizer for its
Covid-19 vaccine.
Because official documents reveal the real reason Moderna is
suing Pfizer for patent infringement,
is due to the fact Moderna
helped create the Covid-19 virus as early as 2013 during gain of
function research and then patented parts of the virus...
This means Moderna
essentially owns SARS-CoV-2.
This may explain why further documents prove Moderna had
developed its Covid-19 vaccine months before the world was aware
Covid-19 even existed.
Moderna has
filed patent infringement lawsuits in the U.S. and
Germany accusing Pfizer and its partner BioNTech of stepping on
patents that Moderna says it filed between 2010 and 2016.
Pfizer says it has not,
"fully reviewed
the complaint" but is "surprised by the litigation given the
Pfizer/BioNTech COVID-19 Vaccine was based on BioNTech's
proprietary mRNA technology and developed by both BioNTech
and Pfizer."
But official
documents and evidence suggest the patent infringement may be
due to Moderna helping to create the Covid-19 virus in a lab
during gain of function research.
Moderna then patented
parts of the SARS-CoV-2 virus as early as 2013. And this may
explain why further official documents prove Moderna had a
Covid-19 vaccine candidate months before Covid-19 was known to
exist officially.
Let's start by looking at the confidential agreement proving
Moderna had a Coronavirus vaccine candidate at least nineteen
days before the alleged emergence of SARS-CoV-2 in
Wuhan, China.
The confidential agreement which can be viewed here states that,
providers 'Moderna' alongside the 'National Institute of Allergy
and Infectious Diseases' (NIAID) agreed to transfer 'mRNA Coronavirus
vaccine candidates' developed and jointly-owned by NIAID and
Moderna to recipients 'the University of North Carolina at
Chapel Hill' on the 12th December 2019.
Source
The material transfer agreement was signed the December 12th
2019 by Ralph Baric, PhD, at the University of North
Carolina at Chapel Hill, and then signed by Jacqueline Quay,
Director of Licensing and Innovation Support at the
University of North Carolina on December 16th 2019.
Source
The agreement was also signed by two representatives of the
NIAID, one of whom was Amy F. Petrik PhD, a technology
transfer specialist who signed the agreement on December 12th
2019 at 8:05 am.
The other signatory
was Barney Graham MD PhD, an investigator for the NIAID,
however, this signature was not dated.
Source
The final signatories of the agreement were Sunny Himansu,
Moderna's Investigator, and Shaun Ryan, Moderna's Deputy
General Counsel.
Both signatures were
made on December 17th 2019.
Source
All of these signatures were made prior to any knowledge of the
alleged emergence of the novel Coronavirus.
It wasn't until
December 31st 2019 that the World Health Organization (WHO)
became aware of an alleged cluster of viral pneumonia cases in
Wuhan, China.
But even at this
point, they had not determined that an alleged new Coronavirus
was to blame, instead stating,
the pneumonia was
of "unknown cause"...
It was not until
January 9th 2020 that the WHO reported Chinese
authorities had determined the outbreak was due to a novel
Coronavirus which later became known as SARS-CoV-2 with
the alleged resultant disease dubbed
COVID-19.
So,
Why was an mRNA
Coronavirus vaccine candidate developed by Moderna being
transferred to the University of North Carolina on December
12th 2019?
What did Moderna know that we didn't?
Could it have something to do with the fact that Covid-19
is a manmade "virus", and Moderna Inc., the American
pharmaceutical and biotechnology company that has made
billions through the sale of an experimental Covid-19
injection, is responsible for creating it?
On February 23 the
Daily Mail ran an article
showing that Moderna has patented the 19 base letter (nucleotide)
sequence which codes for the Furin Cleavage site in Covid-19.
They cited a paper
by scientists in India, Switzerland, Italy and the US, cautiously
entitled
'MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin
Cleavage Site', in which they calculated that,
the chances of
a 19 nucleotide sequence patented by Moderna randomly appearing
in Covid-19 in circumstances where it does not appear anywhere
else in nature are 1 in 3 trillion...
However,
research shows
that Moderna did not merely apply for a patent in 2016 with
US9587003B2, as reported
in the Daily Mail.
They actually
applied in 2013 for 4 patents with,
-
US9149506B2
-
US9216205B2
-
US9255129B2
-
US9301993B2,
...as
well.
So in effect,
Moderna had developed the 19 nucleotide gene sequence containing the
Furin Cleavage Site which gives Covid-19 its infectivity to humans
by patented gain of function research as early as 2013,
6 years
before the Wuhan outbreak took place, not 3 years, as
reported in the Mail and virally elsewhere.
The final codon
completed inserted gene sequence, 'CTCCTCGGCGGGCA', patented by
Moderna, does not exist in natural viruses and neither does the CGG-coded
Furin Cleavage site CCTCGGCGGGCACGT.
But they do exist
naturally in bacteria and in humans and in cows and in plants.
Viruses can
invade bacteria and insert their genes into them.
But bacteria
cannot insert their genes into viruses. Nature has had plenty of
opportunities to put them into viruses and has refused to do so.
Therefore, the only
way for bacterial DNA to end up in a virus is by human
intervention...
So the Covid-19
virus must have been man-made.
We published
two previous articles on this subject in March 2022 that contain
much more scientific detail on the subject at hand.
You can read
Part One here, and
Part Two here.
Part Two
contains the complete method of using the BLAST database to
fact-check this for yourself.
The Covid-19 virus
was not discovered or made in 2019.
It was made
from the 19 nucleotide Moderna
specific chimeric (CGG for AGA) furin cleavage site
which does not occur anywhere in nature as early as 2013...!
That is why Moderna
was able to create an mRNA Coronavirus candidate before Covid-19
officially existed, and it is most likely the reason why they are
now suing Pfizer for 'patent infringement'...
|
